Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-25,467
Closed -$6.23M 536
2025
Q2
$6.23M Buy
25,467
+15,701
+161% +$3.91M 0.02% 515
2025
Q1
$2.58M Sell
9,766
-31
-0.3% -$8.38K 0.01% 686
2024
Q4
$2.49M Sell
9,797
-2,903
-23% -$779K 0.01% 709
2024
Q3
$4.02M Sell
12,700
-38,109
-75% -$13.6M 0.01% 599
2024
Q2
$19M Buy
50,809
+37,614
+285% +$12.7M 0.06% 281
2024
Q1
$4.57M Sell
13,195
-15,481
-54% -$5.87M 0.01% 574
2023
Q4
$13.1M Sell
28,676
-51,184
-64% -$25.2M 0.04% 350
2023
Q3
$38.9M Sell
79,860
-19,588
-20% -$9.21M 0.14% 168
2023
Q2
$44.5M Sell
99,448
-10,856
-10% -$5.47M 0.15% 155
2023
Q1
$53.5M Buy
110,304
+14,391
+15% +$7.11M 0.18% 135
2022
Q4
$49.1M Sell
95,913
-465
-0.5% -$244K 0.18% 140
2022
Q3
$46.8M Buy
96,378
+9,380
+11% +$4.56M 0.18% 130
2022
Q2
$40.7M Buy
86,998
+7,540
+9% +$3.35M 0.15% 158
2022
Q1
$34.6M Sell
79,458
-20,673
-21% -$8.65M 0.1% 241
2021
Q4
$46.4M Sell
100,131
-10,801
-10% -$4.78M 0.12% 201
2021
Q3
$43.2M Buy
110,932
+29,674
+37% +$12.6M 0.12% 203
2021
Q2
$36M Buy
81,258
+26,474
+48% +$11.6M 0.1% 232
2021
Q1
$23M Sell
54,784
-9,900
-15% -$3.95M 0.07% 321
2020
Q4
$26.5M Buy
64,684
+6,333
+11% +$2.63M 0.08% 262
2020
Q3
$24.2M Buy
58,351
+22,549
+63% +$9.07M 0.09% 259
2020
Q2
$13.9M Buy
35,802
+11,654
+48% +$4.36M 0.05% 357
2020
Q1
$7.58M Sell
24,148
-3,805
-14% -$1.28M 0.04% 424
2019
Q4
$10.2M Buy
27,953
+9,344
+50% +$2.96M 0.04% 446
2019
Q3
$4.76M Buy
18,609
+6,459
+53% +$1.81M 0.02% 664
2019
Q2
$3.22M Sell
12,150
-14,667
-55% -$3.72M 0.01% 765
2019
Q1
$7.13M Sell
26,817
-250,033
-90% -$72.1M 0.03% 543
2018
Q4
$79.3M Buy
276,850
+170,494
+160% +$54.1M 0.35% 72
2018
Q3
$36M Buy
106,356
+31,167
+41% +$10.1M 0.13% 203
2018
Q2
$22.4M Buy
75,189
+8,155
+12% +$2.39M 0.09% 268
2018
Q1
$18M Buy
67,034
+1,734
+3% +$469K 0.07% 313
2017
Q4
$16.2M Buy
65,300
+30,400
+87% +$7.51M 0.06% 341
2017
Q3
$8.5M Buy
34,900
+6,800
+24% +$1.67M 0.04% 485
2017
Q2
$6.76M Buy
28,100
+1,200
+4% +$272K 0.03% 527
2017
Q1
$5.54M Buy
26,900
+13,200
+96% +$2.73M 0.03% 576
2016
Q4
$2.79M Hold
13,700
0.01% 698
2016
Q3
$2.42M Sell
13,700
-1,800
-12% -$312K 0.01% 713
2016
Q2
$2.79M Sell
15,500
-2,800
-15% -$497K 0.01% 681
2016
Q1
$3.35M Hold
18,300
0.02% 647
2015
Q4
$3.27M Sell
18,300
-3,100
-14% -$544K 0.01% 669
2015
Q3
$3.83M Sell
21,400
-2,700
-11% -$499K 0.02% 634
2015
Q2
$4.61M Sell
24,100
-9,050
-27% -$1.68M 0.02% 615
2015
Q1
$5.9M Sell
33,150
-10,550
-24% -$1.67M 0.02% 548
2014
Q4
$6.28M Buy
43,700
+3,100
+8% +$424K 0.03% 497
2014
Q3
$5.29M Sell
40,600
-94,500
-70% -$12M 0.02% 521
2014
Q2
$17.3M Sell
135,100
-36,900
-21% -$4.37M 0.07% 298
2014
Q1
$19.4M Sell
172,000
-383,352
-69% -$39.9M 0.08% 261
2013
Q4
$57.3M Sell
555,352
-532,024
-49% -$52.1M 0.26% 106
2013
Q3
$101M Buy
1,087,376
+743,883
+217% +$68.2M 0.5% 45
2013
Q2
$29M Buy
+343,493
New +$27.1M 0.15% 167

Other funds holding HUM

Axa's HUM Position: Q3 2025 in Review

Axa sold out of Humana (HUM) in Q3 2025, closing a stake of 25,467 shares — an estimated $6.23M sold.

Axa first reported a position in HUM in Q2 2013 and held it in 49 quarters. The position peaked at $101M in Q3 2013. 890 funds tracked by Wall St. Rank hold HUM as of Q3 2025.

  • Axa reported no remaining Humana position as of Q3 2025 after selling out during the quarter.
  • Axa sold 25,467 Humana shares in Q3 2025, an estimated $6.23M.
  • Axa first reported a position in Humana in Q2 2013 and held it in 49 quarters.
  • Axa's Humana position peaked at $101M in Q3 2013.
  • 890 funds tracked by Wall St. Rank held Humana as of Q3 2025.

Based on Axa's 13F filing for Q3 2025, filed 14 Nov 2025.